Biochemistry and Biology of GDF11 and Myostatin

Ryan G. Walker(Brigham and Women's Hospital), Tommaso Poggioli(Brigham and Women's Hospital), Lida Katsimpardi(Brigham and Women's Hospital), Sean M. Buchanan(Brigham and Women's Hospital), Juhyun Oh(Brigham and Women's Hospital), Samuel J. Wattrus(Brigham and Women's Hospital), Bettina Heidecker(Brigham and Women's Hospital), Yick W. Fong(Brigham and Women's Hospital), Lee L. Rubin(Brigham and Women's Hospital), Peter Ganz(Brigham and Women's Hospital), Thomas B. Thompson(Brigham and Women's Hospital), Amy J. Wagers(Brigham and Women's Hospital), Richard Lee(Brigham and Women's Hospital)
Circulation Research
March 31, 2016
Cited by 200Open Access
Full Text

Abstract

Growth differentiation factor 11 (GDF11) and myostatin (or GDF8) are closely related members of the transforming growth factor β superfamily and are often perceived to serve similar or overlapping roles. Yet, despite commonalities in protein sequence, receptor utilization and signaling, accumulating evidence suggests that these 2 ligands can have distinct functions in many situations. GDF11 is essential for mammalian development and has been suggested to regulate aging of multiple tissues, whereas myostatin is a well-described negative regulator of postnatal skeletal and cardiac muscle mass and modulates metabolic processes. In this review, we discuss the biochemical regulation of GDF11 and myostatin and their functions in the heart, skeletal muscle, and brain. We also highlight recent clinical findings with respect to a potential role for GDF11 and/or myostatin in humans with heart disease. Finally, we address key outstanding questions related to GDF11 and myostatin dynamics and signaling during development, growth, and aging.


Related Papers

No related papers found

Powered by citation graph analysis